Insiders · Profile

GARVEY CHRISTINE

Director at Toll Brothers · Director at Healthpeak Properties · Director at Prologis. Filing since 11 Jun 2013. CIK 0001073514

Company
Date
Role
Action
Shares
Amount
Of holding
14 Jul 2025
Director
Sold at will
770
$92.26K
6.2%
24 Feb 2025
Director
Sold at will
420
$46.45K
3.1%
30 Dec 2024
Director
Sold at will
204
$25.66K
2.6%
24 Dec 2024
Director
Sold at will
21
$2.66K
0.3%
24 May 2024
Director
Sold at will
170
$20.74K
2.0%
22 Feb 2024
Director
Sold at will
2,160
$239.23K
19.8%
12 Apr 2023
Director
Sold at will
2,980
$179.20K
26.5%
2 Mar 2023
Director
Sold, plan not stated
125
$7.36K
1.1%
23 Feb 2023
Director
Sold, plan not stated
910
$52.76K
7.0%
22 Feb 2023
Director
Sold, plan not stated
1,200
$30.54K
5.0%
28 Dec 2022
Director
Sold, plan not stated
200
$9.92K
2.1%
27 Dec 2022
Director
Sold, plan not stated
1,000
$25.12K
4.0%
16 Nov 2022
Director
Sold, plan not stated
1,860
$46.06K
7.0%
19 Nov 2021
Director
Sold, plan not stated
300
$10.31K
1.3%
9 Sep 2021
Director
Sold, plan not stated
575
$20.81K
2.4%
10 Jun 2021
Director
Sold, plan not stated
889
$30.71K
3.6%
4 Jun 2021
Director
Sold, plan not stated
83
$5.17K
1.2%
6 May 2021
Director
Sold, plan not stated
4,784
$159.73K
16.3%
25 Feb 2021
Director
Sold, plan not stated
340
$10.14K
1.4%
8 Feb 2021
Director
Sold, plan not stated
4,935
$266.29K
100%
23 Nov 2020
Director
Sold, plan not stated
1,340
$41.29K
4.9%
20 Feb 2020
Director
Sold, plan not stated
550
$20.34K
2.4%
3 Jan 2020
Director
Sold, plan not stated
16,954
$691.11K
100%
9 May 2019
Director
Sold, plan not stated
3,405
$101.47K
11.8%
26 Oct 2018
Director
Bought
9
$268.83
0.3%
5 Jan 2018
Director
Sold, plan not stated
16,000
$813.10K
93.8%
14 Dec 2015
Director
Sold, plan not stated
41,000
$1.36M
98.2%
12 May 2014
Director
Sold, plan not stated
5,000
$210.02K
23.2%
7 May 2014
Director
Sold, plan not stated
416
$16.96K
100%
3 Feb 2014
Director
Sold, plan not stated
1,500
$57.33K
36.1%
11 Jun 2013
Director
Sold, plan not stated
1,000
$37.79K
14.1%
31 decisions on file.